JuYeun Jeon

4PUBLICATIONS
36CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Traditional Chinese medicine and treatmentsCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 30, 2025
A First-in-Human Study of Givastomig, a CLDN18.2 and 4-1BB Bispecific Antibody, as Monotherapy in Patients with CLDN18.2-Positive Advanced or Metastatic Solid Tumors.

Geoffrey Ku, Lin Shen, Farshid Dayyani

|Sep 14, 2020
The Impact of COVID-19 on the Conduct of Clinical Trials for Medical Products in Korea.

JuYeun Jeon, Hyeikyoung Kim, Kyung Sang Yu

Pageof 1